Hepatitis C Treatment Options - Research and Clinical Trials: Chronic Hepatitis C End-Stage

Research and Clinical Trials: Chronic Hepatitis C End-Stage
Study to Compare the Efficacy and Safety Among Three Immunosuppressant Treatment Regimens in Patients Receiving a Liver Transplant for End-Stage Liver Disease Caused by Chronic Hepatitis C Infection

Medscape Resource Center - Hepatitis C
Feb 10, 2006 - Antihypertensive drug losartan may reduce liver fibrosis in patients with chronic hepatitis C infection who do not respond to the standard antiviral therapy, the results of a pilot

CASL Hepatology Fellowship
Hepatitis C infection occurs in HIV-positive patients with a frequency between 50-90%. Co-infection results in hepatitis C viral loads that are higher than in the absence of HIV ( 99,100

The Land of Waz and Hepatitis C
Chronic hepatitis C infection is also associated with many autoimmune diseases (where the body develops antibodies which attack parts of itself). For example, about one-tenth of people with chronic